efavirenz and Candidiasis, Oral

efavirenz has been researched along with Candidiasis, Oral in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CM; Chen, HT; Chu, WL; Hsieh, LY; Ko, NY; Ko, WC; Lauderale, TL; Lee, HC; Lee, NY; Lin, CC; Lo, HJ; Tseng, FC; Wang, YL; Wu, CJ; Yang, YL	1
Aklillu, E; Bakari, M; Janabi, MY; Lindquist, L; Minzi, OM; Mugusi, FM; Mugusi, SF; Ngaimisi, E; Sandstrom, EG; Sasi, PG	1
Jaruratanasirikul, S; Mahatthanatrakul, W; Ridtitid, W; Sriwiriyajan, S	1

Trials

1 trial(s) available for efavirenz and Candidiasis, Oral

Article	Year
Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients. European journal of clinical pharmacology, 2007, Volume: 63, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Benzoxazines; Candidiasis, Oral; Cyclopropanes; Drug Interactions; Female; Half-Life; HIV Infections; Humans; Ketoconazole; Lamivudine; Male; Middle Aged; Stavudine	2007

Article

Year

Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.

European journal of clinical pharmacology, 2007, Volume: 63, Issue:5

Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Benzoxazines; Candidiasis, Oral; Cyclopropanes; Drug Interactions; Female; Half-Life; HIV Infections; Humans; Ketoconazole; Lamivudine; Male; Middle Aged; Stavudine

2007

Other Studies

2 other study(ies) available for efavirenz and Candidiasis, Oral

Article	Year
Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Candida; Candidiasis, Oral; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Female; Fluconazole; HIV Infections; HIV-1; Humans; Male; Middle Aged; Oropharynx; Outpatients; Prospective Studies; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Taiwan; Young Adult	2012
Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antiviral therapy, 2012, Volume: 17, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Candidiasis, Oral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Coinfection; Cyclopropanes; Female; HIV Infections; Humans; Karnofsky Performance Status; Leukocyte Count; Male; Middle Aged; Risk Factors; Sarcoma, Kaposi; Tanzania; Tuberculosis	2012

Article

Year

Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:5

Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Candida; Candidiasis, Oral; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Female; Fluconazole; HIV Infections; HIV-1; Humans; Male; Middle Aged; Oropharynx; Outpatients; Prospective Studies; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Taiwan; Young Adult

2012

Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.

Antiviral therapy, 2012, Volume: 17, Issue:2

Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Candidiasis, Oral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Coinfection; Cyclopropanes; Female; HIV Infections; Humans; Karnofsky Performance Status; Leukocyte Count; Male; Middle Aged; Risk Factors; Sarcoma, Kaposi; Tanzania; Tuberculosis

2012